Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Dan Zabrowski; Paul Brown; Ed Southern; Edward Erickson; Kevin Harter

Premium

Dan Zabrowski has been named head of Roche Applied Science, a unit of the company's diagnostics division. Zabrowski replaces Paul Brown, who had held the position since last September.

Zabrowski recently served as global head of Roche Partnering and was a member of the Roche corporate executive committee and the board of Chugai. He joined Roche in 1994 through the acquisition of Syntex. During his career at Roche, Zabrowski has held a number of management positions in regulatory affairs and development.

He holds a PhD in organic chemistry from the University of Indiana.


Oxford Gene Technology founder Ed Southern has been awarded the 2011 Medical Research Council Millennium Medal, OGT said this week.

The medal is awarded to MRC-funded scientists for "outstanding research that has made a major contribution to our mission to improve health, quality of life and wealth creation," according to the publicly funded British organization.

Southern received the award for his "impact on genetic analysis and his invention of both the Southern blotting technique and DNA microarray technology."


Saladax Biomedical said this week that President and CEO Edward Erickson has resigned due to personal reasons, though he will remain a member of the company's board of directors. Cofounder Kevin Harter will take over as president and CEO on an interim basis.

Erickson joined Saladax from genetic analysis firm BioNanoMatrix, now BioNano Genomics, in February last year. Before that, he was president and CEO of nanotechnology startup Y-Carbon from July 2008 to December 2009, and prior to that he held the same positions at Immunicon, a cancer diagnostics firm, until it was acquired by J&J's Veridex subsidiary in 2008.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.